Our previous studies showed a high expression of IL-6/STAT3 pathway proteins in human PDAC specimens (Pozios et al. 2018) and promising results for tumor growth inhibition by blocking this signaling (Pozios et al. 2020). Here, STAT3 is linked to neoplasm.